Ceribell Stock

ceribell.comHealthcare / Medical DevicesFounded: 2014Funding to Date: $153.26MM

Ceribell is the developer of a highly innovative electroencephalography (EEG) device, designed to make the diagnosis of neurological patients drastically more efficient.

Register for Details

For more details on financing and valuation for Ceribell, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Ceribell.

Register Today

Team

Management Team

Raymond Woo Ph.D
Chief Technology Officer
Josef Parvizi MD
Co-Founder, Chief Medical Adviser & Chairman
Chris Chafe
Co-Founder
Jane Chao Ph.D
Chief Executive Officer & Co-Founder

Board Members

Josef Parvizi MD

Other companies like Ceribell in the Medical Devices sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$263MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$943.68MM
Sector
Last Round Est. Valuation
$403.11MM
Sector
Last Round Est. Valuation
$1.35B
Sector
Last Round Est. Valuation
$893.88MM

News Highlights

Ceribell Closes $50 Million Equity Financing Round Led by Ally Bridge Group
Ceribell, Inc. announced today it has closed a $50 million financing round led by new investor Ally Bridge Group, with participation from existing shareholders. The financing was structured as an extension of the company's previously announced Series C financing.
Ceribell Announces Launch Of Clarity, Providing 24/7 Automatic Bedside Monitoring To Enhance EEG Capability
Updated on: Sep 20, 2023